Back to Journals » Breast Cancer: Targets and Therapy » Volume 11 » default

Breast Cancer: Targets and Therapy


Archive: Volume 11, 2019

Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients

Motamedi M, Hashemzadeh Chaleshtori M, Ghasemi S, Mokarian F

Breast Cancer: Targets and Therapy 2019, 11:293-301

Published Date: 25 October 2019

Cryoablation In The Management Of Breast Cancer: Evidence To Date

Pusceddu C, Paliogiannis P, Nigri G, Fancellu A

Breast Cancer: Targets and Therapy 2019, 11:283-292

Published Date: 10 October 2019

Effect of glutaminase inhibition on cancer-induced bone pain

Fazzari J, Singh G

Breast Cancer: Targets and Therapy 2019, 11:273-282

Published Date: 11 September 2019

Mammographic density parameters and breast cancer tumor characteristics among postmenopausal women

Velásquez García HA, Gotay CC, Wilson CM, Lohrisch CA, Lai AS, Aronson KJ, Spinelli JJ

Breast Cancer: Targets and Therapy 2019, 11:261-271

Published Date: 16 August 2019

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice

Liang Y, Besch-Williford C, Cook MT, Belenchia A, Brekken RA, Hyder SM

Breast Cancer: Targets and Therapy 2019, 11:249-259

Published Date: 31 July 2019

Positive margins (R1) risk factors in breast cancer conservative surgery

Lombardi A, Pastore E, Maggi S, Stanzani G, Vitale V, Romano C, Bersigotti L, Vecchione A, Amanti C

Breast Cancer: Targets and Therapy 2019, 11:243-248

Published Date: 26 July 2019

Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy–apoptosis crosstalk pathway

Fleisher B, Mody H, Werkman C, Ait-Oudhia S

Breast Cancer: Targets and Therapy 2019, 11:231-241

Published Date: 23 July 2019

Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study

Ozeki-Hayashi R, Fujita M, Tsuchiya A, Hatta T, Nakazawa E, Takimoto Y, Akabayashi A

Breast Cancer: Targets and Therapy 2019, 11:221-229

Published Date: 17 July 2019

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment

Perelmuter VM, Tashireva LA, Savelieva OE, Denisov EV, Kaigorodova EV, Zavyalova MV, Cherdyntseva NV

Breast Cancer: Targets and Therapy 2019, 11:209-219

Published Date: 5 July 2019

Variation in the management of elderly patients in two neighboring breast units is due to preferences and attitudes of health professionals

Morrow ES, Dolan RD, Doughty J, Stallard S, Lannigan A, Romics L

Breast Cancer: Targets and Therapy 2019, 11:179-188

Published Date: 8 May 2019

Metastasis inhibition in breast cancer by targeting cancer cell extravasation

Cominetti MR, Altei WF, Selistre-de-Araujo HS

Breast Cancer: Targets and Therapy 2019, 11:165-178

Published Date: 18 April 2019

Epidemiological characteristics of and risk factors for breast cancer in the world

Momenimovahed Z, Salehiniya H

Breast Cancer: Targets and Therapy 2019, 11:151-164

Published Date: 10 April 2019

Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women

Nguyen HM, Dao MQ

Breast Cancer: Targets and Therapy 2019, 11:143-150

Published Date: 18 March 2019

Nano-curcumin’s suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression

Hosseini S, Chamani J, Hadipanah MR, Ebadpour N, Hojjati AS, Mohammadzadeh MH, Rahimi HR

Breast Cancer: Targets and Therapy 2019, 11:137-142

Published Date: 13 March 2019

Targeting stem cells in the realm of drug-resistant breast cancer

Dey P, Rathod M, De A

Breast Cancer: Targets and Therapy 2019, 11:115-135

Published Date: 7 March 2019

The antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cells

Crone M, Hallman K, Lloyd V, Szmyd M, Badamo B, Morse M, Dinda S

Breast Cancer: Targets and Therapy 2019, 11:99-110

Published Date: 19 February 2019

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration

Tremmel E, Hofmann S, Kuhn C, Heidegger H, Heublein S, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Mahner S, Ditsch N, Jeschke U, Vattai A

Breast Cancer: Targets and Therapy 2019, 11:87-97

Published Date: 19 February 2019

Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent

Ozdemir BZ, Goodin JB, Bodenner DL

Breast Cancer: Targets and Therapy 2019, 11:81-86

Published Date: 19 February 2019

Overview of the genetic basis toward early detection of breast cancer

De Silva S, Tennekoon KH, Karunanayake EH

Breast Cancer: Targets and Therapy 2019, 11:71-80

Published Date: 21 January 2019

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Butthongkomvong K, Raunroadroong N, Sorrarichingchai S, Sangsaikae I, Srimuninnimit V, Harling H, Larsen S

Breast Cancer: Targets and Therapy 2019, 11:43-51

Published Date: 14 January 2019

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

Antolín S, Acea B, Albaina L, Concha Á, Santiago P, García-Caballero T, Mosquera JJ, Varela JR, Soler R, Calvo L

Breast Cancer: Targets and Therapy 2019, 11:29-42

Published Date: 27 December 2018

Axillary web syndrome following breast cancer surgery: symptoms, complications, and management strategies

Koehler LA, Haddad TC, Hunter DW, Tuttle TM

Breast Cancer: Targets and Therapy 2019, 11:13-19

Published Date: 20 December 2018

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women

Torres-Luquis O, Madden K, N'dri NMR, Berg R, Olopade OF, Ngwa W, Abuidris D, Mittal S, Lyn-Cook B, Mohammed SI

Breast Cancer: Targets and Therapy 2019, 11:1-12

Published Date: 20 December 2018